| pubmed-article:12239445 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12239445 | lifeskim:mentions | umls-concept:C0278996 | lld:lifeskim |
| pubmed-article:12239445 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:12239445 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:12239445 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:12239445 | lifeskim:mentions | umls-concept:C0078257 | lld:lifeskim |
| pubmed-article:12239445 | lifeskim:mentions | umls-concept:C1517927 | lld:lifeskim |
| pubmed-article:12239445 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:12239445 | lifeskim:mentions | umls-concept:C0444889 | lld:lifeskim |
| pubmed-article:12239445 | lifeskim:mentions | umls-concept:C0332283 | lld:lifeskim |
| pubmed-article:12239445 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:12239445 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:12239445 | pubmed:dateCreated | 2002-9-19 | lld:pubmed |
| pubmed-article:12239445 | pubmed:abstractText | We undertook a prospective phase II study to assess the feasibility and activity of a new induction chemotherapy regimen followed by hyperfractionated irradiation in locally advanced squamous cell head and neck cancer. | lld:pubmed |
| pubmed-article:12239445 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12239445 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12239445 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12239445 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12239445 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12239445 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12239445 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12239445 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12239445 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12239445 | pubmed:issn | 0030-2414 | lld:pubmed |
| pubmed-article:12239445 | pubmed:author | pubmed-author:RobertsonChri... | lld:pubmed |
| pubmed-article:12239445 | pubmed:author | pubmed-author:Jereczek-Foss... | lld:pubmed |
| pubmed-article:12239445 | pubmed:author | pubmed-author:OrecchiaRober... | lld:pubmed |
| pubmed-article:12239445 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:12239445 | pubmed:author | pubmed-author:CatalanoGianp... | lld:pubmed |
| pubmed-article:12239445 | pubmed:author | pubmed-author:ChiesaFaustoF | lld:pubmed |
| pubmed-article:12239445 | pubmed:author | pubmed-author:MasciGiovanna... | lld:pubmed |
| pubmed-article:12239445 | pubmed:author | pubmed-author:KrengliMarcoM | lld:pubmed |
| pubmed-article:12239445 | pubmed:author | pubmed-author:VavassoriAndr... | lld:pubmed |
| pubmed-article:12239445 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:12239445 | pubmed:author | pubmed-author:MarroccoEmanu... | lld:pubmed |
| pubmed-article:12239445 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:12239445 | pubmed:author | pubmed-author:DePasTommasoT | lld:pubmed |
| pubmed-article:12239445 | pubmed:copyrightInfo | Copyright 2002 S. Karger AG, Basel | lld:pubmed |
| pubmed-article:12239445 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12239445 | pubmed:volume | 63 | lld:pubmed |
| pubmed-article:12239445 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12239445 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12239445 | pubmed:pagination | 115-23 | lld:pubmed |
| pubmed-article:12239445 | pubmed:dateRevised | 2006-4-24 | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:meshHeading | pubmed-meshheading:12239445... | lld:pubmed |
| pubmed-article:12239445 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12239445 | pubmed:articleTitle | Phase II trial of vinorelbine, cisplatin and continuous infusion of 5-fluorouracil followed by hyperfractionated radiotherapy in locally advanced head and neck cancer. | lld:pubmed |
| pubmed-article:12239445 | pubmed:affiliation | Division of Radiotherapy, European Institute of Oncology, Milan, Italy. roberto.orecchia@ieo.it | lld:pubmed |
| pubmed-article:12239445 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12239445 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12239445 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:12239445 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
